Medtronic gets worldwide rights to bone generating protein
This article was originally published in Clinica
Medtronic Sofamor Danek has obtained worldwide exclusive rights to the recombinant human bone morphogenetic protein rhBMP-2, which was discovered by Wyeth. The new agreement with Wyeth and its licensee, Yamanouchi Pharmaceutical, comes just hours after MSD announced it had obtained rights for Japan and Asia (see Clinica No 1072, p 12). MSD now has global rights to the product in all markets for spinal, orthopaedic and trauma applications.